Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel
- 1 May 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (7) , 934-947
- https://doi.org/10.1016/j.ejca.2005.12.018
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 38 references indexed in Scilit:
- mTOR SignalingCold Spring Harbor Perspectives in Biology, 2011
- The Mammalian Target of Rapamycin-p70 Ribosomal S6 Kinase but Not Phosphatidylinositol 3-Kinase-Akt Signaling Is Responsible for Fibroblast Growth Factor-9-induced Cell ProliferationPublished by Elsevier ,2005
- Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes fromdb/dbmiceThe FASEB Journal, 2004
- Upstream and downstream of mTORGenes & Development, 2004
- Survival pathways meet their endNature, 2004
- TOR SignalingScience's STKE, 2003
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- Translational Control of Cell Fate: Availability of Phosphorylation Sites on Translational Repressor 4E-BP1 Governs Its Proapoptotic PotencyMolecular and Cellular Biology, 2002
- Caspase Cleavage of Initiation Factor 4E-Binding Protein 1 Yields a Dominant Inhibitor of Cap-Dependent Translation and Reveals a Novel Regulatory MotifMolecular and Cellular Biology, 2002
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999